glp-1 costs Medicare Spending on Ozempic and Other GLP-1s Is Skyrocketing Poll: 1 in 8 Adults

The current state of access to weight loss drugs isnt serving everyone who needs them, said Andrew Dudum, CEO and co-founder of Hims & Hers

For comparison, the pain management drug industry which includes antidepressants, opioids, acetaminophen, and ibuprofen was worth $72.3 billion in 2022

all programs are cash-pay FDA status: Compounded medications are not FDA-approved and not reviewed by FDA for safety, effectiveness, or quality before marketing

These initiatives reflect Wisp's commitment to providing affordable, inclusive healthcare for women, complementing WELL's strategic vision of expanding access to high-quality care

At cohort entry, we excluded patients who were less than 18 years of age, had less than one year of medical history in the database, had no diagnosis of type 2 diabetes, had contraindications such as end stage renal disease or multiple endocrine neoplasia, or had concurrent prescriptions for both a GLP-1 receptor agonist and the comparator drug